文献速递衰弱、肌少症与跌倒老年综合评估

全球疾病负担研究衰弱指数(GBD-FI)在SHARE队列中的跨国验证

Comparing frailty prevalence between countries: validation of the Global Burden of Disease study Frailty Index (GBD-FI) in the survey of health, ageing and retirement in Europe.
PubMed 文献 · Age Ageing · 2023-01-01

本研究利用欧洲健康、老龄与退休调查(SHARE)15国31,624名≥50岁参与者的数据,将20项改良GBD-FI与FI-70、临床衰弱量表(CFS)、衰弱表型(FP)及SHARE-FI进行比较,外部验证其诊断与预测效度。GBD-FI对衰弱的诊断准确度良好至优秀(AUC 0.86–0.94),对2年死亡的预测效度与CFS、FP、SHARE-FI相似但低于FI-70。GBD-FI是跨国、跨时间比较衰弱患病率的有效工具。

要点

  • GBD-FI对衰弱的诊断AUC为0.86–0.94,准确度良好至优秀。
  • GBD-FI对2年死亡的预测AUC为0.71,与CFS、FP、SHARE-FI相似。
  • SHARE队列中GBD-FI衰弱患病率为22%,各国从8%至41%不等。

核心结论

  • GBD-FI在SHARE队列中显示出并发效度和预测效度,可作为有效的衰弱测量工具。
  • GBD-FI有潜力利用GBD数据实现跨国、跨时间的一致且可重复的衰弱患病率比较。

研究设计与样本

  • 研究为外部验证研究,数据来自欧洲健康、老龄与退休调查(SHARE)。
  • 共纳入15个国家31,624名年龄≥50岁的参与者。
  • 将20项改良GBD-FI与FI-70、临床衰弱量表(CFS)、衰弱表型(FP)及SHARE-FI进行比较。
  • 通过受试者工作特征曲线下面积(AUC)评估诊断准确度和对2年死亡的预测效度。

主要发现

  • 使用GBD-FI测得的衰弱患病率为22%,范围从瑞士的8%到波兰的41%。
  • GBD-FI对衰弱的诊断AUC从0.86(95%CI 0.85–0.87,以CFS为参照)到0.94(95%CI 0.93–0.94,以FI-70为参照)。
  • GBD-FI对2年死亡的预测AUC为0.71(95%CI 0.69–0.74),与CFS(0.73,P=0.186)、FP(0.73,P=0.392)和SHARE-FI(0.70,P=0.255)相似。
  • GBD-FI对2年死亡的预测AUC低于FI-70(0.76,P<0.001)。

关键数值与推荐

  • GBD-FI对衰弱诊断的AUC范围为0.86至0.94,提示良好至优秀的诊断准确度。
  • GBD-FI对2年死亡预测的AUC为0.71(95%CI 0.69–0.74)。

临床怎么用

  • GBD-FI可用于跨国或跨时间比较衰弱患病率,尤其适用于缺乏可比衰弱数据的地区。
  • 在临床或研究中需快速评估衰弱时,GBD-FI可作为有效工具,但其对死亡预测略逊于FI-70。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate comparable prevalence proportions are required to better understand the epidemiology of frailty. Estimates in many countries are missing or incomparable. The Global Burden of Disease Frailty Index (GBD-FI) applies the deficit accumulation model to generate frailty scores from items available in the Global Burden of Disease study. OBJECTIVE: To externally validate the GBD-FI. METHODS: Data were obtained from the Survey of Health Ageing and Retirement in Europe (SHARE). A 20-item modified GBD-FI was compared with established frailty measures: a 70-item frailty index (FI-70), the Clinical Frailty Scale (CFS), Frailty Phenotype (FP) and SHARE-FI. Area under receiver operating characteristic curves (AUC) were fitted to examine diagnostic accuracy for frailty and predictive validity for 2-year mortality. RESULTS: In total, 31,624 participants aged ≥50 years from 15 countries were included. Frailty prevalence was 22% using the GBD-FI (ranging from 8% in Switzerland to 41% in Poland). The GBD-FI had good to excellent diagnostic accuracy for frailty, irrespective of approach; the AUC ranged from 0.86 (95% confidence interval: 0.85-0.87) measuring frailty using the CFS to 0.94 (0.93-0.94) with the FI-70. The GBD-FI had similar accuracy for 2-year mortality (AUC 0.71, 0.69-0.74) compared with the CFS (0.73; P = 0.186), FP (0.73; P = 0.392) and SHARE-FI (0.70; P = 0.255) but lower than the FI-70 (0.76; P < 0.001). CONCLUSION: The GBD-FI demonstrated concurrent and predictive validity, suggesting it is a valid measure of frailty. It has the potential to be an efficient, replicable and consistent approach to comparing frailty between countries and regions across time using GBD data.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. O'Donovan MR, Devleesschauwer B, Sezgin D, et al. Comparing frailty prevalence between countries: validation of the Global Burden of Disease study Frailty Index (GBD-FI) in the survey of health, ageing and retirement in Europe. Age Ageing. 2023. PMID: 38029517. doi:10.1093/ageing/afad214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。